Search Within

Erin M McGovern

Formats
  1. Meeting Abstract (14)
  2. Journal Article (11)
Groups
  1. Adult Leukemia (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Hematologic Malignancies, Division of (25)
  5. Executive Committee, Center for Hematologic Malignancies (17)
  6. GSK Faculty (17)

More Groups

People
  1. Ross Levine (17)
  2. Noushin Rahnamay Farnoud (16)
  3. Raajit Rampal (15)
  4. Minal Patel (13)
  5. Juan Arango Ossa (9)
  6. Christopher Famulare (8)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (7)

More Years

Publications
  1. Blood (16)
  2. Blood Advances (2)
  3. Clinical Cancer Research (2)
  4. American Journal of Hematology (1)
  5. Cancer Cell (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. American Association for Cancer Research (2)
  3. Amer Soc Clinical Investigation Inc (1)
  4. Cell Press (1)
  5. Elsevier Ltd (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TP53 alterations confer increased risk of leukemic transformation and worse survival as compared to high molecular risk mutations in patients with myeloproliferative neoplasms
    Meeting Abstract

    Handa, S.; Riazat-Kesh, Y. J. R. A.; Butterfield, R. J.; Sivakumar, G.; Venugopal, S.; McGovern, E.; Feld, J.; Tremblay, D.; Elghaity-Beckley, S.; Kremyanskaya, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A phase Ib trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis
    Journal Article

    Mascarenhas, J.; Migliaccio, A. R.; Kosiorek, H.; Bhave, R.; Palmer, J.; Kuykendall, A.; Mesa, R.; Rampal, R. K.; Gerds, A. T.; Yacoub, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis
    Journal Article

    Dunbar, A. J.; Kim, D.; Lu, M.; Farina, M.; Bowman, R. L.; Yang, J. L.; Park, Y.; Karzai, A.; Xiao, W.; Zaroogian, Z.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia
    Journal Article

    Mascarenhas, J.; Kosiorek, H. E.; Prchal, J. T.; Rambaldi, A.; Berenzon, D.; Yacoub, A.; Harrison, C. N.; McMullin, M. F.; Vannucchi, A. M.; Ewing, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features
    Journal Article

    Epstein-Peterson, Z. D.; Spitzer, B.; Derkach, A.; Arango, J. E.; McCarter, J. G. W.; Medina-Martínez, J. S.; McGovern, E.; Farnoud, N. R.; Levine, R. L.; Tallman, M. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
    Journal Article

    Wang, X.; Rampal, R. K.; Hu, C. S.; Tripodi, J.; Farnoud, N.; Petersen, B.; Rossi, M. R.; Patel, M.; McGovern, E.; Najfeld, V.; more...
    JCI Insight (2022)

    Fulltext@MSK | Save
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Treatment of myelofibrosis patients with the TGF-β 1/3 inhibitor AVID200 (MPN-RC 118) induces a profound effect on platelet production
    Meeting Abstract

    Mascarenhas, J.; Kosiorek, H. E.; Bhave, R.; Palmer, J. M.; Kuykendall, A. T.; Mesa, R. A.; Rampal, R.; Gerds, A. T.; Yacoub, A.; Pettit, K. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save